Newsroom

Meet Axcellant at EANM 2024 in Hamburg

Axcellant is excited to announce our participation at the European Association of Nuclear Medicine (EANM) Congress in Hamburg from October…

We are delighted to share exciting news from our team at Axcellant!

Marking a significant achievement in our ongoing efforts to advance medical device research, we have successfully concluded a PMCF study…

Key Considerations for Initiating a Clinical Trial: A Comprehensive Guide

Initiating a clinical trial is akin to embarking on a voyage of discovery in the realm of medicine. This journey,…

Completion of a significant clinical study

Our team at Axcellant is proud to announce the completion of a significant Post-Market Clinical Follow-up study. This study was…

Unveiling Real-World Evidence in Clinical Trials

In the ever-evolving realm of pharmaceuticals and healthcare, a remarkable transformation is afoot - one that's reshaping the way we…

A Closer Look at CRC and CRA Responsibilities

Clinical research is a complex and multifaceted field that relies on the dedicated efforts of a diverse team to bring…

Nuclear Medicine Event – SNMMI in Chicago, 24 – 27 June 2023

Meet our team at top Nuclear Medicine Event – SNMMI in Chicago, 24 - 27 June 2023.

Regulators in the EU to increase the efficiency of paediatric regulatory processes

Regulators in the European Union (EU) have taken several initiatives in the past four years to increase the efficiency of paediatric regulatory processes and boost the development of medicines for children.

Use of Clinical Trials Information System becomes mandatory for new clinical trial applications in the EU

From 31 January 2023, all initial clinical trial applications in the European Union (EU) must be submitted via the Clinical Trials Information System (CTIS).

Facilitating Decentralised Clinical Trials in the EU

The European Commission (EC), the Heads of Medicines Agencies (HMA) and the European Medicines Agency (EMA) have published recommendations that aim to...